|
KBTBD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.81410458771825E-11 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
6.906800E-01 |
| Stage1-vs-Stage3 |
1.739880E-02 |
| Stage1-vs-Stage4 |
3.9182000000082E-06 |
| Stage2-vs-Stage3 |
1.983810E-01 |
| Stage2-vs-Stage4 |
2.522800E-03 |
| Stage3-vs-Stage4 |
4.783600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
3.17020000029089E-07 |
| Normal-vs-Asian |
5.44764233723072E-12 |
| Caucasian-vs-AfricanAmerican |
4.152800E-01 |
| Caucasian-vs-Asian |
5.822000E-01 |
| AfricanAmerican-vs-Asian |
7.123400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.350300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
4.13329999999767E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.566800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.802300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.753400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.392000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.463800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.707600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.992600E-04 |
| Classical-VS-Follicular |
2.846200E-01 |
| Classical-VS-Other |
6.679200E-01 |
| Classical-VS-Normal |
4.32320845789036E-13 |
| Tall-VS-Follicular |
2.620600E-04 |
| Tall-VS-Other |
1.715410E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
9.582800E-01 |
| Follicular-VS-Normal |
2.99580360518803E-11 |
| Other-VS-Normal |
3.580200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
6.476100E-03 |
|
|
